LUCAS WONG to Drug Administration Schedule
This is a "connection" page, showing publications LUCAS WONG has written about Drug Administration Schedule.
Connection Strength
0.150
-
High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer. J Oncol Pharm Pract. 2017 Apr; 23(3):173-178.
Score: 0.118
-
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC. Lung Cancer. 2017 09; 111:108-115.
Score: 0.032